PENTADECAPEPTIDE BPC 157 THERAPY IN BILE DUCT LIGATED (BDL) RATS. IN THE LIVER TISSUE, BPC 157 COUNTERACTS THE INCREASED NOS3 EXPRESSION, IL-6, TNF-alpha, IL-1 beta LEVELS, AND KI-67 PRESENTATION

when colonoscopy was high-quality.Our results suggest that following a high-quality screening colonoscopy there is no need to undergo further screening colonoscopy for 15 years.Table 1.SIRs and SMRs of colorectal cancer after high-and low-quality single negative screening colonoscopy across follow-up time.Time from screen-Quality of screening ing colonoscopy SIR (95% CI) SMR (95% CI) colonoscopy (years) Low 0.1-3.00.30 (0.23-0.39) 0.11 (0.05-0.21) 3.1-5.00.46 (0.35-0.60) 0.12 (0.05-0.24) 5.1-10.00.62 (0.52-0.72) 0.42 (0.31-0.55) 10.1-16.40.58 (0.41-0.78) 0.46 (0.26-0.74)High 0.1-3.00.12 (0.06-0.22) 0.05 (0.01-0.18) 3.1-5.00.23 (0.12-0.39) 0.07 (0.01-0.26) 5.